Listar por materia "Supraclavicular lymphadenopathy"
Mostrando publicaciones 1-1 de 1
-
Xeloda oral, trastuzumab, and pertuzumab combined drug therapy reduced cervical lymphadenopathy and dermal involvement in patient with recurrent breast cancer: case report
(2020)We report the case of a 42-year-old woman who was diagnosed with breast cancer that recurred 3 years later, with supraclavicular lymphadenopathy and dermal involvement. The main drug used in the therapy was trastuzumab; ...